2 unchanged sentences
Description of Exhibit
−Removed: First Amendment to Agreement and Plan of Merger, dated as of April 4, 2023, by and among MedTech Acquisition Corporation, MTAC Merger Sub, Inc., and TriSalus Life Sciences, Inc.
+Added: Second Amendment to Amended and Restated Certificate of Incorporation.
+Added: Second Amendment to Agreement and Plan of Merger, dated as of May 13, 2023, by and among MedTech Acquisition Corporation, MTAC Merger Sub, Inc., and TriSalus Life Sciences, Inc.
+Added: Backstop Letter Agreement, dated as of June 7, 2023, by and between MedTech Acquisition Corporation and MedTech Acquisition Sponsor LLC.
+Added: Promissory Note issued to MedTech Acquisition Sponsor LLC, dated June 15, 2023.(3)
+Added: Third Amendment to Agreement and Plan of Merger, dated as of July 5, 2023, by and among MedTech Acquisition Corporation, MTAC Merger Sub, Inc., and TriSalus Life Sciences, Inc.
+Added: Form of Subscription Agreement.
+Added: Letter Agreement, dated as of July 4, 2023, by and between MedTech Acquisition Corporation and MedTech Acquisition Sponsor LLC.
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
13 unchanged sentences
Furnished herewith.
−Removed: Incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on April 5, 2023.
+Added: (1) Incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on May 15, 2023.
+Added: (2) Incorporated herein by reference to Exhibits to the Company’s Current Report on Form 8-K, filed with the SEC on June 8, 2023.
+Added: (3) Incorporated herein by reference to Exhibits to the Company’s Current Report on Form 8-K, filed with the SEC on June 15, 2023.
+Added: (4) Incorporated herein by reference to Exhibits to the Company’s Current Report on Form 8-K, filed with the SEC on July 6, 2023.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MEDTECH ACQUISITION CORPORATION
+Added: August 1, 2023
/s/ Christopher C.
2 unchanged sentences
(Principal Executive Officer)
+Added: August 1, 2023
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.